ElliotWaveTrades

ESPR: 2nd Chance To Go Long ?

เพิ่มขึ้น
ElliotWaveTrades ที่อัปเดต:   
NASDAQ:ESPR   Esperion Therapeutics, Inc.
ESPR rallied 85% from its last consolidation to its near term high at $57.38.
Prices have since been in consolidation mode in the form of a expanded FLAT.

The consolidation appears to be completed.
A successful break to the upside could bring prices to a range between $82.24 (Fib Exp 1.5x) to $85.36 (Fib Exp 1.618x)

Break of Critical Support could imply any of the following possibilities:

(1) A much larger scale FLAT is forming where prices could likely find support between the range of $20 and $30.
(2) Prices are in an A-B-C correction and will break its Nov 2016 low of $9.40

Till then, the operative wave structure supports the bullish bias to break upwards from current price.
ความคิดเห็น:
Prices have reached a short term critical juncture.
A break above $51.33 will increase the probability of the initial analysis.

On the other hand, a break of the short term critical low will imply the other alternative scenarios mentioned.

ความคิดเห็น:
Prices have turned up from key support and is now testing its near term resistance.
This is the 2nd time prices are testing this resistance.
Though not necessary, prices could consolidate for a short period before attempting a break above this resistance.
The momentum is still to the upside.

ความคิดเห็น:
Prices have broken above the near term resistance turned support.
Momentum is good but average breakout volume has taken the shine off the break up.
To sustain the upward momentum after breakout, volume will be critical.

ความคิดเห็น:
Prices appear to be consolidating sideways around the $52 to $65 range.
As long as prices do not break key support, we can expect more upside.

ปิดการเทรด: ถึงเป้าหมายการทำกำไร:
Consolidation appears complete.

Trade at your own time and target.

Happy Trading.
ความคิดเห็น:

ไอเดียที่เกี่ยวข้อง

คำจำกัดสิทธิ์ความรับผิดชอบ

ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมที่ เงื่อนไขการใช้บริการ